Author | Enrique Grande, MD | OncLive

Author | Enrique Grande, MD

Articles

Dr. Grande on the Rationale of the IMvigor130 Trial in Urothelial Cancer

December 07, 2019

Video

Enrique Grande, MD, discusses the rationale of the IMvigor130 trial in urothelial cancer.

Dr. Grande on the IMvigor130 Trial in Metastatic Urothelial Cancer

October 17, 2019

Video

Enrique Grande, MD, discusses the design of the phase III IMvigor130 trial, which compared atezolizumab plus chemotherapy versus atezolizumab monotherapy (arm B) versus standard chemotherapy plus placebo in patients with previously untreated locally advanced or metastatic urothelial carcinoma.

x